Status:
COMPLETED
Switch From Metformin Monotherapy to a Bitherapy With Metformin and Repaglinide
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Brief Summary
This study is conducted in Europe. The aim of this observational study is to investigate the efficacy (e.g. glycemic control) and safety (e.g. hypoglycemic episodes) when adding repaglinide to a monot...
Eligibility Criteria
Inclusion
- Type 2 diabetes
- Metformin monotreatment
- HbA1c greater than 7%
- Treatment according to SPC
- Informed consent obtained
Exclusion
- Any contraindication to the use of repaglinide (according to the SPC)
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2009
Estimated Enrollment :
906 Patients enrolled
Trial Details
Trial ID
NCT00745433
Start Date
January 1 2008
End Date
March 1 2009
Last Update
November 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brussels, Belgium, 1070